BioNexus Gene Lab (BGLC) Current Deferred Revenue (2021 - 2026)
BioNexus Gene Lab recorded quarterly Current Deferred Revenue of $8416.0 in Q1 2026, little changed quarter-over-quarter from $8385.0 in Q4 2025, and down 61.68% year-over-year from $21964.0 in Q1 2025.
BioNexus Gene Lab's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $8416.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 61.68% year-over-year to $8416.0; the TTM figure through Mar 2026 stood at $8416.0 (down 61.68% YoY), while the FY2025 annual figure was $8385.0, down 91.25% from the prior year.
- Current Deferred Revenue came in at $8416.0 for Q1 2026 at BioNexus Gene Lab, roughly flat from $8385.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $95879.0 in Q4 2024 to a low of $107.0 in Q1 2022.
- A 5-year average of $18453.2 and a median of $11264.0 in 2025 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue soared 14219.63% in 2023 and slumped 91.25% in 2025, its largest moves.
- BioNexus Gene Lab's Current Deferred Revenue stood at $23123.0 in 2022, then sank by 64.46% to $8218.0 in 2023, then soared by 1066.7% to $95879.0 in 2024, then plunged by 91.25% to $8385.0 in 2025, then rose by 0.37% to $8416.0 in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $8416.0, $8385.0, and $11264.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,416.00 |
| Dec 31, 2025 | 8,385.00 |
| Sep 30, 2025 | 11,264.00 |
| Jun 30, 2025 | 11,348.00 |
| Mar 31, 2025 | 21,964.00 |
| Dec 31, 2024 | 95,879.00 |
| Sep 30, 2024 | 22,834.00 |
| Jun 30, 2024 | 5,937.00 |
| Sep 30, 2023 | 8,218.00 |
| Jun 30, 2023 | 7,094.00 |
| Mar 31, 2023 | 15,322.00 |
| Dec 31, 2022 | 23,123.00 |
| Dec 31, 2021 | 30,307.00 |